Investing.com - DarioHealth reported on Monday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
DarioHealth announced earnings per share of $-0.64 on revenue of $6.61M. Analysts polled by Investing.com anticipated EPS of $-0.76 on revenue of $6.29M.
DarioHealth shares are down 71% from the beginning of the year , still down 77.33% from its 52 week high of $17.29 set on Monday, November 15, 2021.
DarioHealth shares gained 9.44% in after-hours trade the report.
DarioHealth follows other major Healthcare sector earnings this month
DarioHealth's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar